Healthcare
•3753 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3753)
| Company | Market Cap | Price |
|---|---|---|
|
LIMN
Liminatus Pharma, Inc. Class A Common Stock
Monoclonal antibody therapeutics tag reflects LIMN's lead anti-CD47 antibody program as a targeted biologic for cancer.
|
$20.01M |
$0.75
-3.68%
|
|
NOTV
Inotiv, Inc.
Inotiv operates as a CRO delivering nonclinical drug discovery and development services, aligning with the Contract Research Organizations tag.
|
$19.52M |
$0.58
+1.41%
|
|
CVM
CEL-SCI Corporation
Direct product category for CEL-SCI's lead immunotherapy for cancer (Multikine) under oncology biotech.
|
$19.30M |
$6.07
-4.64%
|
|
INTS
Intensity Therapeutics, Inc.
Company develops oncology-focused therapeutics (INT230-6.00) and operates in Biotech - Oncology.
|
$19.21M |
$0.41
-1.70%
|
|
MDXH
MDxHealth S.A.
MDxHealth's portfolio includes liquid-based diagnostic tests (Select mdx, Resolve mdx, ExoDx) that fit the Liquid Biopsy category.
|
$19.01M |
$3.85
+3.91%
|
|
NXPL
NextPlat Corp
Management is pivoting toward higher-margin healthcare services and 340B contracts, a Healthcare Services & Facilities focus.
|
$18.95M |
$0.72
-0.21%
|
|
BCAB
BioAtla, Inc.
Oz-V and Mec-V are ADCs (CAB-ROR2-ADC, CAB-AXL-ADC) - major product modality.
|
$18.92M |
$0.33
+3.25%
|
|
LSTA
Lisata Therapeutics, Inc.
Certepetide is a proprietary peptide therapeutic, fitting Peptide Therapeutics.
|
$18.91M |
$2.17
-0.69%
|
|
PMN
ProMIS Neurosciences, Inc.
PMN310 is a monoclonal antibody therapeutic targeting toxic amyloid-beta oligomers for Alzheimer's disease.
|
$18.63M |
$8.62
-1.54%
|
|
KAPA
Kairos Pharma, Ltd.
Kairos Pharma is a clinical-stage biopharma focused on oncology therapies, including immunotherapies and cell therapies.
|
$18.10M |
$0.87
-1.96%
|
|
ALLR
Allarity Therapeutics, Inc.
Allarity is a clinical-stage biotech focused on oncology therapies (stenoparib) and cancer drug development.
|
$17.25M |
$1.18
-0.42%
|
|
CLGN
CollPlant Biotechnologies Ltd.
rhCollagen is a recombinant protein, and CollPlant's core product is plant-derived recombinant human collagen used in implants, fillers, and bioinks.
|
$17.18M |
$1.47
-6.37%
|
|
SIGY
Sigyn Therapeutics, Inc.
Sigyn Therapy is a broad-spectrum blood purification device designed to remove pathogens, toxins, and inflammatory mediators from blood.
|
$17.09M |
$0.50
|
|
EVOK
Evoke Pharma, Inc.
Gimoti relies on a nasal drug-delivery platform/technology, making Drug Delivery Platforms a core investable theme for Evoke's product strategy.
|
$17.07M |
$10.98
+0.32%
|
|
LEXX
Lexaria Bioscience Corp.
Lexaria's DehydraTECH is a proprietary drug delivery platform that enhances API absorption and enables oral formulations.
|
$16.86M |
$0.72
-1.07%
|
|
PFHO
Pacific Health Care Organization, Inc.
PFHO provides workers' compensation cost containment services, including healthcare provider network access and case management, within the healthcare services ecosystem.
|
$16.51M |
$1.29
|
|
APYP
AppYea, Inc.
AppySleep devices function as medical devices/biometrics for sleep disorders.
|
$16.32M |
$0.03
|
|
OSRH
OSR Holdings, Inc.
VAXIMM's lead oncology immunotherapy candidate positions OSRH in the Biotech - Oncology space.
|
$16.13M |
$0.75
-4.54%
|
|
CVKD
Cadrenal Therapeutics, Inc. Common Stock
Cadrenal's tecarfarin is described as a novel oral small-molecule therapeutic, directly aligning with the 'Oral Small Molecule Therapeutics' tag.
|
$16.11M |
$8.11
-1.10%
|
|
DSY
Big Tree Cloud Holdings Limited
Provides OEM/ODM manufacturing services, i.e., contract manufacturing for others.
|
$16.07M |
$0.28
+0.14%
|
|
KNW
Know Labs, Inc.
Core product: KnowU CGM wearable and glucose monitoring device.
|
$16.05M |
$2.14
|
|
UEEC
United Health Products, Inc.
CelluSTAT is a surgical hemostatic device used in operative settings, categorizing the company as a Surgical Equipment manufacturer.
|
$16.04M |
$0.06
|
|
COSM
Cosmos Health Inc.
Owns/operates in-house EU GMP manufacturing via Cana Laboratories Holdings Cyprus Ltd. and Cana S.A., enabling contract manufacturing revenue.
|
$15.85M |
$0.53
-2.47%
|
|
RBOT
Vicarious Surgical Inc.
The company directly manufactures and sells surgical equipment in a robotic system for minimally invasive surgery.
|
$15.77M |
$2.66
-6.99%
|
|
TOMZ
TOMI Environmental Solutions, Inc.
Product category aligns with healthcare-themed medical devices and equipment, including disinfection hardware (SteraMist SIS/CES).
|
$15.46M |
$0.79
+1.16%
|
|
BMGL
Basel Medical Group Ltd Ordinary Shares
BMGL provides hospital-style healthcare services, including inpatient/outpatient care via clinics and integrated care delivery.
|
$15.30M |
$0.85
+2.19%
|
|
LESL
Leslie's, Inc.
AccuBlue water-testing systems and related diagnostic testing capabilities are direct testing instruments offered to customers.
|
$15.22M |
$1.65
-4.07%
|
|
ITRM
Iterum Therapeutics plc
ORLYNVAH is an oral small molecule antibiotic (sulopenem) that the company is launching commercially.
|
$15.20M |
$0.33
+3.70%
|
|
LIXT
Lixte Biotechnology Holdings, Inc.
LB-100 is Lixte's lead oncology drug candidate (PP2A inhibitor) being developed for cancer therapy, constituting the primary product/offerable asset.
|
$15.14M |
$3.33
-2.35%
|
|
PALI
Palisade Bio, Inc.
Lead asset PALI-2108 targets immunology/inflammatory diseases (IBD), aligning with Immunology Therapeutics.
|
$15.14M |
$1.67
-4.86%
|
|
CASI
CASI Pharmaceuticals, Inc.
CID-103 is a monoclonal antibody therapeutic, a core product class for the company.
|
$14.84M |
$0.95
-8.64%
|
|
COCH
Envoy Medical, Inc.
Envoy Medical designs and manufactures implantable medical devices with biometric sensing capabilities (Acclaim CI and Esteem FI-AMEI).
|
$14.79M |
$0.67
-0.92%
|
|
CTXR
Citius Pharmaceuticals, Inc.
LYMPHIR is a targeted oncology immunotherapy for CTCL, representing a core commercial product.
|
$14.60M |
$0.84
-1.35%
|
|
ADAP
Adaptimmune Therapeutics plc
Adaptimmune develops engineered T-cell therapies (cell therapy) for cancer, including TECELRA and lete-cel.
|
$14.58M |
$0.06
+2.91%
|
|
APLT
Applied Therapeutics, Inc.
Applied Therapeutics is a biotech focused on rare diseases, with lead programs in rare metabolic/neurologic conditions (e.g., govorestat for CMT-SORD) and out-licensing efforts in rare disease assets.
|
$14.44M |
$0.09
-7.36%
|
|
VYNE
VYNE Therapeutics Inc.
Company's core focus is immunology therapeutics powered by a BET inhibitor platform.
|
$14.44M |
$0.57
-0.04%
|
|
CODX
Co-Diagnostics, Inc.
Co-Dx PCR Pro instrument is a diagnostic equipment product directly manufactured by the company.
|
$14.43M |
$0.35
-6.19%
|
|
ALUR
Allurion Technologies Inc.
Allurion Balloon is a swallowable medical device used for weight management.
|
$14.36M |
$1.84
-2.65%
|
Showing page 32 of 38 (3753 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
